A multigene RT-PCR assay used to predict recurrence in early breast cancer: two presentations with contradictory results


During the 2003 San Antonio Breast Cancer Symposium two studies were presented that were designed to validate a recurrence score, derived from a 21-gene RT-PCR assay, in patients with axillary node-negative breast cancer. This recurrence score was highly predictive for the risk of recurrence in 668 patients treated in a large multicenter trial with adjuvant… (More)
DOI: 10.1186/bcr911